Mariner
CTKB icon

Mariner’s Cytek Biosciences CTKB Stock Holding History

Mariner’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.8K Sell
17,807
-758
-4% -$3.58K ﹤0.01% 3364
2025
Q4 		$93.7K Sell
18,565
-8,337
-31% -$38.7K ﹤0.01% 3340
2025
Q3 		$93.3K Buy
26,902
+9,663
+56% +$36.3K ﹤0.01% 3373
2025
Q2 		$58.6K Buy
+17,239
New +$57.4K ﹤0.01% 3325
2025
Q1 		– Sell
-13,098
Closed -$85K – 3473
2024
Q4 		$85K Sell
13,098
-2,219
-14% -$13.2K ﹤0.01% 3215
2024
Q3 		$84.9K Sell
15,317
-215
-1% -$1.22K ﹤0.01% 3118
2024
Q2 		$86.6K Sell
15,532
-2,412
-13% -$14.5K ﹤0.01% 2982
2024
Q1 		$120K Buy
17,944
+1,877
+12% +$14.8K ﹤0.01% 2898
2023
Q4 		$147K Buy
+16,067
New +$101K ﹤0.01% 2775

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return